Anlon Healthcare
add_icon

Anlon Healthcare

135.58
-6.84
(-4.80%)
Market Cap
720.63 Cr
PE Ratio
37.14
Volume
1,21,659.00
Day High - Low
144.40 - 132.32
52W High-Low
172.75 - 90.78
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
720.63 Cr
EPS
6.37
PE Ratio
37.14
PB Ratio
3.78
Book Value
37.90
EBITDA
32.40
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
25.51
Debt to Equity
1.46
Forecast For
Actual

Company News

View All News
Caret
neutral
Neomile Asset Managers sold 13.07 lakh shares of Anlon Healthcare through open market transactions, reducing their holding from 7.62% to 5.16% between November 2025 and January 2026.
neutral
Neomile Asset Managers and its funds disposed of 13.07 lakh shares in Anlon Healthcare, reducing their combined stake from 7.62% to 5.16% through open market transactions between November 2025 and January 2026.
positive
Anlon Healthcare Limited successfully completed acquisition of 67.48% equity stake in Apiqo Organics Private Limited on January 9, 2026, making it a subsidiary under SEBI regulations.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,736.00
#1 4,16,524.55
39.59
#1 54,729.00
9.71
#1 10,980
2.89
46.04
6,485.50
1,72,169.65
70.69
9,712.00
18.67
2,191
35.10
51.18
3,949.80
1,33,679.18
62.67
11,539.40
6.99
1,911
30.46
60.02
1,465.20
1,18,354.72
21.80
28,409.50
7.12
5,291
3.71
38.70
1,215.50
1,01,449.32
#1 17.59
33,741.20
16.73
5,725
-0.38
34.09
2,188.40
99,965.85
22.92
22,909.50
13.74
3,306
#1 72.75
64.68
2,224.30
91,820.23
51.19
12,744.20
#1 20.90
2,007
-21.05
51.35
895.05
90,062.97
17.91
23,511.00
18.55
4,615
34.60
35.98
5,867.00
70,148.79
28.77
13,458.30
3.70
2,216
10.98
66.62
1,172.90
68,122.22
20.35
32,345.60
9.43
3,484
3.81
41.95
Growth Rate
Revenue Growth
80.66 %
Net Income Growth
111.34 %
Cash Flow Change
-598.14 %
ROE
-44.45 %
ROCE
43.74 %
EBITDA Margin (Avg.)
15.12 %

Yearly Financial Results

Annual Financials
2021
2022
2023
2024
2025
TTM
Revenue
16
58
113
67
121
148
Expenses
21
52
101
51
88
113
EBITDA
-5
6
13
16
32
35
Operating Profit %
-33 %
9 %
11 %
23 %
27 %
24 %
Depreciation
2
2
2
2
2
2
Interest
3
4
4
4
4
4
Profit Before Tax
-10
-0
7
10
27
29
Tax
0
0
1
0
6
9
Net Profit
-10
-0
6
10
21
20
EPS in ₹
-8.53
-0.09
4.85
6.68
6.37
6.40

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
71
85
112
128
181
Fixed Assets
29
27
26
27
23
Current Assets
40
58
86
101
159
Capital Work in Progress
0
0
0
0
0
Investments
0
2
4
1
1
Other Assets
43
56
82
100
158
Total Liabilities
71
85
112
128
181
Current Liabilities
31
29
44
50
60
Non Current Liabilities
38
55
61
57
41
Total Equity
2
2
7
21
80
Reserve & Surplus
-10
-10
-5
5
41
Share Capital
12
12
12
16
40

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
Net Cash Flow
-2
1
-1
2
-1
Investing Activities
-3
-0
-0
-3
3
Operating Activities
-15
-2
-3
-3
-23
Financing Activities
16
3
2
8
19

Share Holding

% Holding
Oct 2024
Apr 2025
Jun 2025
Aug 2025
Sept 2025
Dec 2025
Promoter
70.26 %
70.26 %
52.68 %
70.26 %
52.68 %
52.68 %
FIIs
0.00 %
0.00 %
14.42 %
0.00 %
0.00 %
0.23 %
DIIs
0.00 %
0.00 %
4.35 %
0.00 %
2.83 %
4.49 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
14.64 %
0.00 %
20.73 %
23.58 %
Others
29.74 %
29.74 %
13.92 %
29.74 %
23.75 %
19.02 %
No of Share Holders
109
131
9,125
135
9,126
11,412

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2025 139.10 142.50

Announcements

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20113 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20113 days ago
Announcement With Continuation Of Our Earlier Intimation Dated December 02 2025 Regarding The Execution Of Share Purchase Agreement Dated December 2 2025.3 days ago
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report5 days ago
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot5 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20185 days ago
Closure of Trading WindowDec 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 23, 2025
Announcement As Per Reg. 30 Of SEBI (LODR) Regulation 2015Dec 19, 2025
Results-Delay in Financial ResultsDec 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 09, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 08, 2025
Board Meeting Outcome for Held On Friday December 05 2025Dec 05, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsDec 02, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsNov 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 25, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 19, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 13, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 12, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 12, 2025
Statement Of Deviation & VariationNov 11, 2025
Financial Result For The Quarter And Half Year Ended September 30 2025.Nov 11, 2025
Board Meeting Outcome for To Consider And Approve The Financial Result For The Quarter And Half Year Ended September 30 2025Nov 11, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Nov 07, 2025
Board Meeting Intimation for Consider And Approve The Financial Results For The Quarter And Half Year Ended September 30 2025.Nov 06, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Nov 06, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday October 16 2025Oct 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 14, 2025
Board Meeting Intimation for Consider General Business Matter.Oct 13, 2025
Closure of Trading WindowSep 29, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 29, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday September 27 2025Sep 27, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 27, 2025
Board Meeting Intimation for Consider And Approve Proposal For Purchase Of Immovable Property.Sep 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 22, 2025
Announcement As Per Regulation 30 Of SEBI LODR Regulations 2015 For Development Of New Product.Sep 20, 2025
Clarification On Price Movement Regarding Letter Received From L/SURV/ONL/PV/AJ/ 2025-2026 / 3092Sep 18, 2025
Clarification sought from Anlon Healthcare LtdSep 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 17, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 15, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 13, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 10, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Sep 09, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Sep 09, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Sep 08, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Sep 04, 2025

Technical Indicators

RSI(14)
Neutral
46.09
ATR(14)
Less Volatile
7.09
STOCH(9,6)
Neutral
39.70
STOCH RSI(14)
Neutral
37.23
MACD(12,26)
Bullish
0.03
ADX(14)
Weak Trend
24.77
UO(9)
Bearish
40.16
ROC(12)
Uptrend And Accelerating
2.85
WillR(14)
Neutral
-75.84